Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Expanded_access × Afatinib × Other solid neoplasm × Clear all

Status

No longer available 1

Sponsor Class

Study Type

Interventional 2 Expanded_access 1

Sponsor

Cancer Type

Thoracic 3 Other solid neoplasm 1

Conditions

Interventions

tazemetostat 1 osunprotafib 1 omburtamab I-131 1 molibresib 1 marizomib 1 Pemetrexed 1 Cisplatin 1 Afatinib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05107193 2022-11-08

Afatinib (GILOTRIF®) in Patients Suffering From Tumors Harboring Neuregulin 1 (NRG1) Gene Alterations (Specifically NRG1 Gene Fusion-positive Advanced Solid Tumors)

Boehringer Ingelheim

No longer available

Other solid neoplasm

Solid Tumors

Data powered by HemOnc (CC BY 4.0) Colophon ⚡